3Dipakk, Richard, M, Engelman, et al. Molecular targets of gene therapy. Ann Thor Surg, 1999;68(5) : 1929 - 1933.
4Wright MJ,Wightman LML, Latchman DS, et al. In vivo myocardial gene transfer:optimization and evaluation of intracoronary gene delivery in vivo. Gene Therapy, 2001; 8: 1833-1839.
5Davidson MJ Jones JM, Emami S, et al. Cardiac gondelivery with cardiopulmonary bypass. Circulation, 2001; 104:131 -133.
6MiyamotoMI, delMonteF, SchmidtU, et al. Adenoviral gene-transfer of SERCA2 aim proves left ventricular function in aortic - banded rats intransition to hear tfailure. Proc NatlAcad Sci USA,2000;97:793 - 798.
7Hell, MeyerM, MartinJL, et al. Effects of mutantand antisense RNA of phospholambanon SRCa(2 + ) - AT ase activity and cardiacmyocyte contractility. Circulation, 1999; 100:974 -980.
8Casilde Sesti, Robert A. Kloner, MD, PhD Gene Therapy in Congestive Heart Failuae. Circulation. 2004,110:242 - 243.
9Tam SK, GuW, Nadal - Ginard B. Molecular eardiomy - oplasty: potential cardiac gene therapy for chronic heart failure. J Thorae CardiovasCSurg, 1995 ; 109(5) :918- 9238.
10Prabhu SD, Chandrasekar B, et al. B - Adrenergic Blockade in DevelOping Heart Failare: Egects on Myocardial lnnammatory Cytokines, NibiC Oxide, and Remodeling. CirculatiOn,2000; 101(17) : 2103 - 2109.
